Svas Biosana SpA

MIL:SVS

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SVS's stock price target?

Price Target

14.84 EUR

According to Wall Street analysts, the average 1-year price target for SVS is 14.84 EUR with a low forecast of 12.12 EUR and a high forecast of 17.96 EUR.

What is the Revenue forecast for Svas Biosana SpA?

Projected CAGR

7%

Over the last 5 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 4 years is 7%.

What is the Gross Profit forecast for Svas Biosana SpA?

Projected CAGR

26%

Over the last 5 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 26%.

What is the Operating Income forecast for Svas Biosana SpA?

Projected CAGR

9%

Over the last 5 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 4 years is 9%.

What is the Pre-Tax Income forecast for Svas Biosana SpA?

Projected CAGR

-14%

Over the last 5 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 2 years is -14%.

What is the Net Income forecast for Svas Biosana SpA?

Projected CAGR

15%

Over the last 5 years, the compound annual growth rate for Net Income has been 19%. The projected CAGR for the next 3 years is 15%.